THE BOARD OF DIRECTORS OF PRECISE BIOMETRICS RESOLVES ON ISSUE AND REPURCHASE OF SHARES OF SERIES C RELATED TO LTI 2022/2028

The Annual General Meeting of Precise Biometrics on May 19, 2022 resolved to authorize the Board of Directors to resolve on a directed issue of convertible and redeemable shares of series C in Precise Biometrics, in order to secure the company’s obligations pursuant to the long-term incentive program LTI 2022/2028 resolved at the Annual General Meeting. The Annual General Meeting also resolved to authorize the Board of Directors to resolve on repurchase of all issued shares of series C through an acquisition offer addressed to all owners of shares of series C.

The Board of Directors has resolved to exercise the authorizations by issuing 1,085,000 new shares of series C to Vator Securites AB and immediately repurchasing all shares of series C. The issue was completed at a price corresponding to the quota value of the shares, and the shares of series C are repurchased for SEK 355,500.

The repurchase of shares of series C is intended to take place in December 2022. The company currently holds no treasury shares. Following completion of the repurchase, the number of shares of series C held by Precise Biometrics will amount to 1,085,000. The shares of series C do not entitle to any dividends.

The repurchased shares of series C are intended to be converted into ordinary shares in connection with the delivery of shares to the participants in LTI 2022/2028, in accordance with the terms and conditions of the incentive program.